Drug factory · FDA FEI 1942094

Alcami Carolinas Corporation

4260 Forest Park Avenue, St. Louis, MO, United States

United States: 1

Problems found, fixed voluntarily at FDA's last inspection, Oct 4, 2024.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

7 drug inspections on record since 2009: 2 with no problems, 5 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
Buprenorphine and NaloxoneTests it Indivior Inc. 12496-1202, 12496-1204, 12496-1208 +1
GemcitabineTests it Janssen Biotech, Inc. 57894-225
MethadoneTests it Breckenridge Pharmaceutical, Inc. 51991-002
MorphineTests it Nortec Development Associates, Inc. 42689-005, 42689-006, 42689-007 +3
PeramivirTests it BioCryst Pharmaceuticals, Inc. 72769-181

FDA inspection history

EndedResultProgramProblems noted
Oct 4, 2024Problems found, fixed voluntarilyDrug Quality Assurance—
Jan 16, 2020No problems foundDrug Quality Assurance—
Mar 28, 2017Problems found, fixed voluntarilyDrug Quality Assurance2
Jan 14, 2015Problems found, fixed voluntarilyDrug Quality Assurance—
Jan 31, 2014Problems found, fixed voluntarilyDrug Quality Assurance—
Feb 3, 2012Problems found, fixed voluntarilyDrug Quality Assurance—
Nov 20, 2009No problems foundDrug Quality Assurance—

What inspectors wrote down

From FDA's Form 483 citations: conditions an investigator observed that may violate drug manufacturing rules, as FDA published them.

Mar 28, 2017 inspection

Registered with FDA for: analysis.